Results for this period
Full year1 January 2025 to 31 December 2025ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in Millions of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
生成AI関連など先端半導体パッケージ基板向け製品の需要が堅調に推移し、薬品出荷量が増加したことや収益性の高い製品の需要が堅調であったことにより営業利益が増加した。経常利益は為替の影響等を受けて増加し、純利益は補助金収入の計上や前期の法人税等の増加も寄与して大幅に増加した。
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2025 to 31 December 2025 |
| Net Sales | 20,947 Millions of yen (YoY +14.9%) |
| Operating profit | 5,748 Millions of yen (YoY +26.0%) |
| Ordinary income | 6,051 Millions of yen (YoY +29.2%) |
| Profit attributable to owners of the parent | 5,028 Millions of yen (YoY +119.4%) |
| Net income per share | 272.14円 |
| Operating Margin | 27.4% |
| Equity ratio | End of the current fiscal period 83.7% / End of previous period 81.4% |
| Total assets | 36,424 Millions of yen |
| Net assets | 30,472 Millions of yen |
| Cash flows from operating activities | 3,979 Millions of yen |
| Cash flows from investing activities | -3,394 Millions of yen |
| Cash flows from financing activities | -2,252 Millions of yen |
| Cash and cash equivalents at end of period | 8,749 Millions of yen |
| Full-year earnings forecast | Net Sales 22,500 Millions of yen (YoY +7.4%) / Operating profit 6,500 Millions of yen (YoY +13.1%) / Ordinary income 6,550 Millions of yen (YoY +8.2%) / Net income 4,600 Millions of yen (YoY -8.5%) |
| Annual Dividend Forecast | ¥45 → ¥96(+113.3%) |
| Payout ratio | 35.3% |
| Segment revenue | Japan 7,827 Millions of yen (YoY +8.6%), Taiwan 3,887 Millions of yen (YoY +16.9%), Zhuhai (China) 2,780 Millions of yen (YoY +20.6%), Suzhou (China) 3,953 Millions of yen (YoY +9.9%), Europe 1,393 Millions of yen (YoY +40.8%), Thailand 1,106 Millions of yen (YoY +36.5%) |
| Segment profit | Japan 4,301 Millions of yen (YoY +23.7%), Taiwan 506 Millions of yen (YoY +26.6%), Zhuhai (China) 324 Millions of yen (YoY -7.0%), Suzhou (China) 563 Millions of yen (YoY +12.6%), Europe 19 Millions of yen (YoY -71.4%), Thailand 199 Millions of yen (YoY +95.8%) |
| Regional sales | 7,827 Millions of yen (YoY +8.6%), 3,887 Millions of yen (YoY +16.9%), 2,780 Millions of yen (YoY +20.6%), 3,953 Millions of yen (YoY +9.9%), 1,393 Millions of yen (YoY +40.8%), 1,106 Millions of yen (YoY +36.5%) |
| Depreciation and amortization | 823 Millions of yen |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥4,362 thousand, Subsidy Income ¥546,447 thousand, Gain on reversal of foreign currency translation adjustment ¥23,448 thousand / Extraordinary loss Loss on sale of fixed assets ¥344 thousand, Loss on Disposal of Fixed Assets ¥152,183 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 1社(MEC(HONG KONG)LTD.) |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 19,571,093 |
| Treasury Shares at Period-End | 1,310,436 |
| Factors Behind Changes in Business Performance | 生成AI関連など先端半導体パッケージ基板向け製品の需要が堅調に推移し、薬品出荷量が増加したことや収益性の高い製品の需要が堅調であったことにより営業利益が増加した。経常利益は為替の影響等を受けて増加し、純利益は補助金収入の計上や前期の法人税等の増加も寄与して大幅に増加した。 |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.生成AI関連など先端半導体パッケージ基板向け製品の需要が堅調に推移し、薬品出荷量が増加したことや収益性の高い製品の需要が堅調であったことにより利益が増加した。加えて、特別利益に補助金収入を計上したことや、前期にグループ再編に伴う法人税等の増加があったことも、親会社株主に帰属する当期純利益の増加要因となった。